Treatment of pediatric high‐grade central nervous system tumors with high‐dose methotrexate in combination with multiagent chemotherapy: A single‐institution experience

Pediatric Blood & Cancer ◽

10.1002/pbc.28119 ◽

2019 ◽

Vol 67 (3) ◽

Author(s):

Joshua D. Bernstock ◽

Elizabeth Alva ◽

Joshua L. Cohen ◽

Mina Lobbous ◽

Gustavo Chagoya ◽

...

Keyword(s):

Central Nervous System ◽

Nervous System ◽

Central Nervous System Tumors ◽

High Dose ◽

High Dose Methotrexate ◽

Single Institution ◽

Nervous System Tumors ◽

Dose Methotrexate ◽

Multiagent Chemotherapy

Download Full-text

EPT-23TREATMENT OF HIGH-GRADE CENTRAL NERVOUS SYSTEM TUMORS WITH HIGH-DOSE METHOTREXATE IN COMBINATION WITH MULTI-AGENT CHEMOTHERAPY: A SINGLE INSTITUTION EXPERIENCE

Neuro-Oncology ◽

10.1093/neuonc/now069.22 ◽

2016 ◽

Vol 18 (suppl 3) ◽

pp. iii29-iii29

Author(s):

Elizabeth Alva ◽

Gregory Friedman ◽

Rong Li ◽

Curtis Rozzelle ◽

Brandon Rocque ◽

...

Keyword(s):

Central Nervous System ◽

Nervous System ◽

Central Nervous System Tumors ◽

High Dose ◽

High Dose Methotrexate ◽

Single Institution ◽

Nervous System Tumors ◽

Dose Methotrexate ◽

Download Full-text

Clinical outcomes of patients with newly diagnosed primary central nervous system lymphoma are comparable on treatment with high-dose methotrexate plus temozolomide and with high-dose methotrexate plus cytarabine: a single-institution experience

Leukemia & Lymphoma ◽

10.3109/10428194.2014.889823 ◽

2014 ◽

Vol 55 (11) ◽

pp. 2497-2501 ◽

Author(s):

Xiao-xiao Wang ◽

Hui-qiang Huang ◽

Bing Bai ◽

Qing-qing Cai ◽

Qi-chun Cai ◽

...

Keyword(s):

Central Nervous System ◽

Nervous System ◽

Clinical Outcomes ◽

Central Nervous System Lymphoma ◽

High Dose ◽

High Dose Methotrexate ◽

Newly Diagnosed ◽

Single Institution ◽

Dose Methotrexate

Download Full-text

ABCL-241: Comparing Efficacy of Intrathecal Chemotherapy versus High-Dose Methotrexate for Central Nervous System Prophylaxis in High-Grade B-Cell Lymphomas

Clinical Lymphoma Myeloma & Leukemia ◽

10.1016/s2152-2650(21)01875-9 ◽

2021 ◽

Vol 21 ◽

pp. S384

Author(s):

Nicole Ianniello ◽

Jose Sandoval-Sus

Keyword(s):

Central Nervous System ◽

Nervous System ◽

B Cell ◽

Intrathecal Chemotherapy ◽

High Dose ◽

High Dose Methotrexate ◽

B Cell Lymphomas ◽

Dose Methotrexate ◽

Central Nervous System Prophylaxis

Download Full-text

Primary central nervous system lymphoma treated with high-dose methotrexate and rituximab: A single-institution experience

Oncology Letters ◽

10.3892/ol.2016.4393 ◽

2016 ◽

Vol 11 (5) ◽

pp. 3471-3476 ◽

Author(s):

K. INA LY ◽

LAURA L. CREW ◽

CARRIE A. GRAHAM ◽

MACIEJ M. MRUGALA

Keyword(s):

Central Nervous System ◽

Nervous System ◽

Central Nervous System Lymphoma ◽

High Dose ◽

High Dose Methotrexate ◽

Single Institution ◽

Dose Methotrexate

Download Full-text

Outcome of primary central nervous system lymphoma treated with combined surgical resection and high-dose methotrexate chemotherapy: a single-institution retrospective study

Turkish Neurosurgery ◽

10.5137/1019-5149.jtn.24054-19.2 ◽

2019 ◽

Author(s):

Qiujian Zhang ◽

Dawei Wang ◽

Hansheng Shu

Keyword(s):

Central Nervous System ◽

Nervous System ◽

Retrospective Study ◽

Surgical Resection ◽

Central Nervous System Lymphoma ◽

High Dose ◽

High Dose Methotrexate ◽

Single Institution ◽

Dose Methotrexate ◽

Methotrexate Chemotherapy

Download Full-text

Poster: ABCL-241: Comparing Efficacy of Intrathecal Chemotherapy versus High-Dose Methotrexate for Central Nervous System Prophylaxis in High-Grade B-Cell Lymphomas

Clinical Lymphoma Myeloma & Leukemia ◽

10.1016/s2152-2650(21)01515-9 ◽

2021 ◽

Vol 21 ◽

pp. S241

Author(s):

Nicole Ianniello ◽

Jose Sandoval-Sus

Keyword(s):

Central Nervous System ◽

Nervous System ◽

B Cell ◽

Intrathecal Chemotherapy ◽

High Dose ◽

High Dose Methotrexate ◽

B Cell Lymphomas ◽

Dose Methotrexate ◽

Central Nervous System Prophylaxis

Download Full-text

Prognostic impact of completion of initial high-dose methotrexate therapy on primary central nervous system lymphoma: a single institution experience

International Journal of Clinical Oncology ◽

10.1007/s10147-014-0692-4 ◽

2014 ◽

Vol 20 (1) ◽

pp. 29-34 ◽

Author(s):

Keishi Makino ◽

Hideo Nakamura ◽

Taku-ichiro Hide ◽

Jun-ichiro Kuroda ◽

Shigetoshi Yano ◽

...

Keyword(s):

Central Nervous System ◽

Nervous System ◽

Central Nervous System Lymphoma ◽

Methotrexate Therapy ◽

High Dose ◽

Prognostic Impact ◽

High Dose Methotrexate ◽

Single Institution ◽

Dose Methotrexate

Download Full-text

High-dose methotrexate for metastatic breast cancer to the central nervous system: A single-institution review of 46 patients.

Journal of Clinical Oncology ◽

10.1200/jco.2014.32.15_suppl.1079 ◽

2014 ◽

Vol 32 (15_suppl) ◽

pp. 1079-1079 ◽

Author(s):

Margaret A. Schwartz

Keyword(s):

Breast Cancer ◽

Central Nervous System ◽

Nervous System ◽

Metastatic Breast ◽

High Dose ◽

High Dose Methotrexate ◽

Single Institution ◽

System A ◽

Dose Methotrexate ◽

The Central Nervous System

Download Full-text

Comparing the Efficacy of DeVIC Therapy and High-dose Methotrexate Monotherapy with Whole-brain Radiation Therapy for Newly-diagnosed Primary Central Nervous System Lymphoma: A Single Institution Study

Anticancer Research ◽

10.21873/anticanres.11945 ◽

2017 ◽

Vol 37 (9) ◽

Keyword(s):

Central Nervous System ◽

Nervous System ◽

Central Nervous System Lymphoma ◽

High Dose ◽

High Dose Methotrexate ◽

Newly Diagnosed ◽

Single Institution ◽

Whole Brain Radiation ◽

Dose Methotrexate ◽

Brain Radiation

Download Full-text

PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA (PCNSL), RETROSPECTIVE ANALYSIS OF COMBINED CHEMO-RADIATION USING HIGH DOSE METHOTREXATE, EXPERIENCE FROM A SINGLE INSTITUTE

Research in Oncology ◽

10.21608/resoncol.2009.404 ◽

2009 ◽

Vol 5 (Issue 1-2) ◽

pp. 39-45

Author(s):

Mahmoud Abdelsalam

Keyword(s):

Central Nervous System ◽

Nervous System ◽

Retrospective Analysis ◽

Central Nervous System Lymphoma ◽

High Dose ◽

High Dose Methotrexate ◽

Dose Methotrexate

Download Full-text